All Stories

  1. Comparison of the 7th and 8th Editions of the AJCC/UICC TNM Staging System for Differentiated Thyroid Cancer

    Article • Thyroid, June 2017, Mary Ann Liebert Inc

    WON GU KIM

  2. Serial Neck Ultrasonographic Evaluation of Changes in Papillary Thyroid Carcinoma During Pregnancy

    Article • Thyroid, June 2017, Mary Ann Liebert Inc

    WON GU KIM

  3. Preoperative clinicopathological characteristics of patients with solitary encapsulated follicular variants of papillary thyroid carcinomas

    Article • Journal of Surgical Oncology, June 2017, Wiley

    WON GU KIM

  4. Excessive Iodine Intake and Thyrotropin Reference Interval: Data from the Korean National Health and Nutrition Examination Survey

    Article • Thyroid, May 2017, Mary Ann Liebert Inc

    WON GU KIM

  5. Growth Kinetics of Macronodular Lung Metastases and Survival in Differentiated Thyroid Carcinoma

    Article • Thyroid, May 2017, Mary Ann Liebert Inc

    WON GU KIM

  6. Clinical outcomes after delayed thyroid surgery in patients with papillary thyroid microcarcinoma

    Article • European Journal of Endocrinology, April 2017, Bioscientifica

    WON GU KIM

  7. Dynamic Risk Stratification for Predicting Recurrence in Patients with Differentiated Thyroid Cancer Treated Without Radioactive Iodine Remnant Ablation Therapy

    Article • Thyroid, April 2017, Mary Ann Liebert Inc

    WON GU KIM

  8. Features of papillary thyroid microcarcinoma associated with lateral cervical lymph node metastasis

    Article • Clinical Endocrinology, March 2017, Wiley

    WON GU KIM, Tae Yong Kim

  9. Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center’s Experience in Korea

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2017, Endocrine Society

    Tae Yong Kim, WON GU KIM

  10. Association between thyroid autoimmunity and Helicobacter pylori infection

    Article • The Korean Journal of Internal Medicine, March 2017, Korean Association of Internal Medicine (KAMJE)

    WON GU KIM

  11. A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study

    Article • European Journal of Endocrinology, January 2017, Bioscientifica

    WON GU KIM

  12. Clinical Features of Early and Late Postoperative Hypothyroidism After Lobectomy

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2017, Endocrine Society

    WON GU KIM, Tae Yong Kim

  13. Initial Size of Metastatic Lesions Is Best Prognostic Factor in Patients with Metastatic Differentiated Thyroid Carcinoma Confined to the Lung

    Article • Thyroid, January 2017, Mary Ann Liebert Inc

    WON GU KIM

  14. Thyroid Stimulating Hormone Reference Range and Prevalence of Thyroid Dysfunction in the Korean Population: Korea National Health and Nutrition Examination Survey 2013 to 2015

    Article • Endocrinology and Metabolism, January 2017, Korean Endocrine Society (KAMJE)

    WON GU KIM

  15. Serum vitamin D3 levels are not associated with thyroid cancer prevalence in euthyroid subjects without autoimmune thyroid disease

    Article • The Korean Journal of Internal Medicine, January 2017, Korean Association of Internal Medicine (KAMJE)

    WON GU KIM

  16. Impact of Reclassification on Thyroid Nodules with Architectural Atypia: From Non-Invasive Encapsulated Follicular Variant Papillary Thyroid Carcinomas to Non-Invasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features

    Article • PLoS ONE, December 2016, PLOS

    WON GU KIM

  17. Initial and Dynamic Risk Stratification of Pediatric Patients with Differentiated Thyroid Cancer

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2016, Endocrine Society

    WON GU KIM

  18. Optimal cut-off age in the TNM Staging system of differentiated thyroid cancer: is 55 years better than 45 years?

    Article • Clinical Endocrinology, November 2016, Wiley

    WON GU KIM

  19. Early prognostic factors at the time of diagnosis of bone metastasis in patients with bone metastases of differentiated thyroid carcinoma

    Article • European Journal of Endocrinology, June 2016, Bioscientifica

    WON GU KIM

  20. Clinical usefulness of dynamic risk stratification in medullary thyroid cancer

    Article • Endocrine Abstracts, May 2016, Bioscientifica

    WON GU KIM

  21. Genomic Alterations of Anaplastic Thyroid Carcinoma Detected by Targeted Massive Parallel Sequencing in aBRAFV600EMutation-Prevalent Area

    Article • Thyroid, May 2016, Mary Ann Liebert Inc

    WON GU KIM

  22. Dynamic risk stratification for medullary thyroid cancer according to the response to initial therapy

    Article • Endocrine, January 2016, Springer Science + Business Media

    WON GU KIM

  23. Features Predictive of Distant Metastasis in Papillary Thyroid Microcarcinomas

    Article • Thyroid, January 2016, Mary Ann Liebert Inc

    WON GU KIM

  24. Usefulness of Measuring Thyroid Stimulating Antibody at the Time of Antithyroid Drug Withdrawal for Predicting Relapse of Graves Disease

    Article • Endocrinology and Metabolism, January 2016, Korean Endocrine Society (KAMJE)

    WON GU KIM

  25. Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells

    Article • Molecular and Cellular Endocrinology, January 2016, Elsevier

    WON GU KIM

  26. Low Prevalence of SomaticTERTPromoter Mutations in Classic Papillary Thyroid Carcinoma

    Article • Endocrinology and Metabolism, January 2016, Korean Endocrine Society (KAMJE)

    WON GU KIM

  27. Molecular Diagnosis Using Residual Liquid-Based Cytology Materials for Patients with Nondiagnostic or Indeterminate Thyroid Nodules

    Article • Endocrinology and Metabolism, January 2016, Korean Endocrine Society (KAMJE)

    WON GU KIM

  28. Changing trends in the clinicopathological features and clinical outcomes of medullary thyroid carcinoma

    Article • Journal of Surgical Oncology, December 2015, Wiley

    WON GU KIM

  29. Negative Expression of CPSF2 Predicts a Poorer Clinical Outcome in Patients with Papillary Thyroid Carcinoma

    Article • Thyroid, September 2015, Mary Ann Liebert Inc

    WON GU KIM

  30. Metformin Is Associated with a Favorable Outcome in Diabetic Patients with Cervical Lymph Node Metastasis of Differentiated Thyroid Cancer

    Article • European Thyroid Journal, August 2015, Karger Publishers

    WON GU KIM

  31. Sub-Classification of Lateral Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma by Pathologic Criteria

    Article • PLoS ONE, July 2015, PLOS

    WON GU KIM

  32. Clinicopathological Significance of Minimal Extrathyroid Extension in Solitary Papillary Thyroid Carcinomas

    Article • Annals of Surgical Oncology, June 2015, Springer Science + Business Media

    WON GU KIM

  33. Changes in the Pulmonary Function Test after Radioactive Iodine Treatment in Patients with Pulmonary Metastases of Differentiated Thyroid Cancer

    Article • PLoS ONE, April 2015, PLOS

    WON GU KIM

  34. Thyroglobulin Level in Fine-Needle Aspirates for Preoperative Diagnosis of Cervical Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma: Two Different Cutoff Values According to Serum Thyroglobulin Level

    Article • Thyroid, April 2015, Mary Ann Liebert Inc

    WON GU KIM

  35. Association between Serum Gamma-Glutamyl Transferase and Thyroid Cancer in an Ultrasonographically Screened Population

    Article • Journal of Korean Thyroid Association, January 2015, Korean Thyroid Association (KAMJE)

    WON GU KIM

  36. Lack of Associations between Body Mass Index and Clinical Outcomes in Patients with Papillary Thyroid Carcinoma

    Article • Endocrinology and Metabolism, January 2015, Korean Endocrine Society (KAMJE)

    WON GU KIM

  37. Association between neck ultrasonographic findings and clinico-pathological features in the follicular variant of papillary thyroid carcinoma

    Article • Clinical Endocrinology, December 2014, Wiley

    WON GU KIM

  38. Metformin blocks progression of obesity-activated thyroid cancer in a mouse model

    Article • Oncotarget, November 2014, Impact Journals, LLC

    WON GU KIM

  39. A cut-off value of basal serum calcitonin for detecting macroscopic medullary thyroid carcinoma

    Article • Clinical Endocrinology, September 2014, Wiley

    WON GU KIM

  40. NRASCodon 61 Mutation Is Associated with Distant Metastasis in Patients with Follicular Thyroid Carcinoma

    Article • Thyroid, August 2014, Mary Ann Liebert Inc

    WON GU KIM

  41. Differentiating the location of cervical lymph node metastasis is very useful for estimating the risk of distant metastases in papillary thyroid carcinoma

    Article • Clinical Endocrinology, May 2014, Wiley

    WON GU KIM

  42. Effects of Low-Dose and High-Dose Postoperative Radioiodine Therapy on the Clinical Outcome in Patients with Small Differentiated Thyroid Cancer Having Microscopic Extrathyroidal Extension

    Article • Thyroid, May 2014, Mary Ann Liebert Inc

    WON GU KIM

  43. Low Levels of Serum Vitamin D3 Are Associated with Autoimmune Thyroid Disease in Pre-Menopausal Women

    Article • Thyroid, April 2014, Mary Ann Liebert Inc

    WON GU KIM

  44. Association Between Expression of X-Linked Inhibitor of Apoptosis Protein and the Clinical Outcome in aBRAFV600E-Prevalent Papillary Thyroid Cancer Population

    Article • Thyroid, April 2014, Mary Ann Liebert Inc

    WON GU KIM

  45. Inhibition of Tumorigenesis by the Thyroid Hormone Receptor β in Xenograft Models

    Article • Thyroid, February 2014, Mary Ann Liebert Inc

    WON GU KIM

  46. Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data

    Article • The Korean Journal of Internal Medicine, January 2014, Korean Association of Internal Medicine (KAMJE)

    Professor Young Suk Jo, WON GU KIM

  47. Current Status and Future Perspectives in Differentiated Thyroid Cancer

    Article • Endocrinology and Metabolism, January 2014, Korean Endocrine Society (KAMJE)

    WON GU KIM

  48. Time Trends Analysis of Characteristics of Patients with Thyroid Cancer in a Single Medical Center

    Article • Journal of Korean Thyroid Association, January 2014, Korean Thyroid Association (KAMJE)

    WON GU KIM

  49. Standardized Thyroid Cancer Mortality in Korea between 1985 and 2010

    Article • Endocrinology and Metabolism, January 2014, Korean Endocrine Society (KAMJE)

    WON GU KIM

  50. Solitary Skin Metastasis of Papillary Thyroid Carcinoma

    Article • Endocrinology and Metabolism, January 2014, Korean Endocrine Society (KAMJE)

    WON GU KIM

  51. The effect of 5-aminoimidazole-4-carboxamide-ribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells

    Article • The Korean Journal of Internal Medicine, January 2014, Korean Association of Internal Medicine (KAMJE)

    WON GU KIM

  52. Diet-Induced Obesity Increases Tumor Growth and Promotes Anaplastic Change in Thyroid Cancer in a Mouse Model

    Article • Endocrinology, August 2013, Endocrine Society

    WON GU KIM

  53. Reactivation of the Silenced Thyroid Hormone Receptor β Gene Expression Delays Thyroid Tumor Progression

    Article • Endocrinology, January 2013, Endocrine Society

    WON GU KIM

  54. Long-Term Consequence of Elevated Thyroglobulin in Differentiated Thyroid Cancer

    Article • Thyroid, January 2013, Mary Ann Liebert Inc

    WON GU KIM

  55. Positive Cytology Findings and a Negative Histological Diagnosis of Papillary Thyroid Carcinoma in the Thyroid: Is It a False-Positive Cytology or a Disappearing Tumor

    Article • European Thyroid Journal, January 2013, Karger Publishers

    WON GU KIM

  56. Papillary thyroid carcinoma arising from a thyroglossal duct cyst: a single institution experience

    Article • Endocrine Journal, January 2013, Japan Endocrine Society

    WON GU KIM

  57. Alpha-lipoic acid induces sodium iodide symporter expression in TPC-1 thyroid cancer cell line

    Article • Nuclear Medicine and Biology, November 2012, Elsevier

    WON GU KIM

  58. Long-Term Clinical Outcome of Differentiated Thyroid Cancer Patients with Undetectable Stimulated Thyroglobulin Level One Year After Initial Treatment

    Article • Thyroid, August 2012, Mary Ann Liebert Inc

    WON GU KIM

  59. Association between STAT1 activity and BRAF mutations in papillary thyroid carcinomas

    Article • Journal of Surgical Oncology, April 2012, Wiley

    WON GU KIM

  60. The long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level at one year after initial treatment

    Article • Thyroid, March 2012, Mary Ann Liebert Inc

    WON GU KIM

  61. Alpha-Lipoic Acid Decreases Iodine Uptake in the Rat Thyroid Cell Line FRTL-5

    Article • Journal of Korean Thyroid Association, January 2012, Korean Thyroid Association (KAMJE)

    WON GU KIM

  62. Effects of different doses of radioactive iodine for remnant ablation on successful ablation and on long-term recurrences in patients with differentiated thyroid carcinoma

    Article • Nuclear Medicine Communications, October 2011, Wolters Kluwer Health

    WON GU KIM

  63. The Outcomes of First Reoperation for Locoregionally Recurrent/Persistent Papillary Thyroid Carcinoma in Patients Who Initially Underwent Total Thyroidectomy and Remnant Ablation

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2011, Endocrine Society

    WON GU KIM

  64. The Outcomes of Adjuvant Radioactive Ablation Therapy after Reoperation for Locoregionally Recurrent/Persistent Papillary Thyroid Carcinoma in Patients Who Initially Underwent Total Thyroidectomy and Remnant Ablation

    Article • June 2011, Endocrine Society

    WON GU KIM

  65. The Long-Term Clinical Outcome of Differentiated Thyroid Carcinoma Patients Who Initially Underwent Total Thyroidectomy and Remnant Ablation, and with Undetectable Stimulated Thyroglobulin Level One Year after Remnant Ablation

    Article • June 2011, Endocrine Society

    WON GU KIM

  66. Four Cases of Malignant Pleural Effusion in Patients with Papillary Thyroid Carcinoma

    Article • Endocrinology and Metabolism, January 2011, Korean Endocrine Society (KAMJE)

    WON GU KIM

  67. Expression of X-linked Inhibitor of Apoptosis Protein in Neoplastic Thyroid Disorder

    Article • Journal of Korean Medical Science, January 2011, Korean Academy of Medical Sciences (KAMJE)

    WON GU KIM

  68. Comparison of Different Staging Systems for Predicting Recurrence of Papillary Thyroid Carcinoma

    Article • Endocrinology and Metabolism, January 2011, Korean Endocrine Society (KAMJE)

    WON GU KIM

  69. Concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma in the same thyroid should be considered as coincidental

    Article • Clinical Endocrinology, February 2010, Wiley

    WON GU KIM

  70. Response: Effects of α-lipoic Acid on Differentiation of Thyroid Cancer Cells

    Article • Endocrinology and Metabolism, January 2010, Korean Endocrine Society (KAMJE)

    WON GU KIM

  71. Effects of α-lipoic Acid on Differentiation of Thyroid Cancer Cells

    Article • Journal of Korean Endocrine Society, January 2010, Korean Endocrine Society (KAMJE)

    WON GU KIM

  72. Clinical Outcomes of Persistent Radioiodine Uptake in the Neck Shown by Diagnostic Whole Body Scan in Patients with Differentiated Thyroid Carcinoma after Initial Surgery and Remnant Ablation

    Article • Clinical Endocrinology, January 2010, Wiley

    WON GU KIM

  73. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma

    Article • Clinical Endocrinology, September 2009, Wiley

    WON GU KIM

  74. Effects of Peroxisome Proliferator-Activated Receptor (PPAR) Delta on the Growth and Invasion of a Thyroid Cancer Cell Line

    Article • Journal of Korean Endocrine Society, January 2009, Korean Endocrine Society (KAMJE)

    WON GU KIM

  75. Redifferentiation Therapy with 13-cis Retinoic Acids in Radioiodine-Resistant Thyroid Cancer

    Article • Endocrine Journal, January 2009, Japan Endocrine Society

    WON GU KIM

  76. Change of Serum Antithyroglobulin Antibody Levels Is Useful for Prediction of Clinical Recurrence in Thyroglobulin-Negative Patients with Differentiated Thyroid Carcinoma

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2008, Endocrine Society

    WON GU KIM

  77. Prognostic parameters for recurrence of papillary thyroid microcarcinoma

    Article • BMC Cancer, October 2008, Springer Science + Business Media

    WON GU KIM

  78. A Case of Carcinoma Showing Thymus-Like Differentiation (CASTLE) in the Thyroid

    Article • Journal of Korean Endocrine Society, January 2008, Korean Endocrine Society (KAMJE)

    WON GU KIM

  79. Effects of Simvastatin on the Growth and Invasion of Anaplastic Thyroid Cancer Cells Lines

    Article • Journal of Korean Endocrine Society, January 2008, Korean Endocrine Society (KAMJE)

    WON GU KIM